why choose us

First received: March 18, 2023

Clinical Trial: AD816 Crossover Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: OSA

Study Type: INTERVENTIONAL


Official Title: Phase 2 Randomized Double-Blind Placebo-Controlled Multiple-Dose 3-Period Crossover Study to Compare a Fixed Dose Combination of AD816 to Viloxazine Alone and to Placebo in Obstructive Sleep Apnea

Brief Summary: The VicTor Study is a randomized, double blind, placebo-controlled, 3-period, multiple-dose crossover study in participants with OSA.

Read more